Are you climate change deniers happy? It was fine when paranoid Americans cast doubt upon the 4th estate because by-and-large, major media outlets shill their toxic ideologies to teevee watchers. But then you turned your pitch forks on scientists, and that is when you made a fatal mistake. Our best DNA editing research is moving offshore. Intella Therapeutics announced Monday that China’s State Intellectual Property Office plans to grant the company a patent covering the CRISPR/Cas9 single-guide gene editing methods and compositions.
Intella [ticker: $NTLA] can now operate in China, free to explore the powers of DNA editing for the explicit benefit of their people.
As you might imagine, the prospect of taking CRISPR research out from beneath the thumb of a collectively ignorant populace and their authoritarian leader is creating quite a bit of excitement in this small corner of the biotech industry. Your gods cannot stops shares of DNA editing companies like SGMO, NTLA, and EDIT from racing higher*.
*writer’s note: I am long SGMO, NTLA, and EDIT
So like most breakthroughs in science, the crowd is being proven wrong. Natural forces are prevailing.
In other CRISPR news, Sangamo (which sounds like a nice Italian name) successfully raised $72.5 million dollars on Wednesday via a secondary stock offering. This secondary was received surprisingly well by investors. Just over 24 hours after issuing 10,000,000 shares at a price of $7.25 the stock is trading over $9. This offering speaks to the overall health of equity markets. It also tells investors that $SGMO has their affairs in order because successfully completing a secondary is a shit-ton of work, especially for a small outfit like Sangamo.
So there you have it. Despite the primates in congress and their apish behavior, science is prevailing. DNA editing research shall press onward…in China.
Long live science
Long live discovery
No more living in the past in summary!
If you enjoy the content at iBankCoin, please follow us on Twitter